Technology News and Research

RSS

Emerald BioStructures, SomaLogic announce strategic collaboration for SOMAmers

Emerald BioStructures, a leading provider of integrated structural biology services, and SomaLogic, Inc., a diagnostics and biomarker discovery company, today announced that they have entered into a strategic collaboration for the structure-based design of chemically modified DNA aptamers and small molecule therapeutics, based on crystal structures of important protein targets bound to high affinity SOMAmers.

3 Sep 2010

ECRI Institute's 17th Annual Conference to be held October 19-20, at NIH

With the advent of healthcare reform, the United States is embarking on an unprecedented effort to determine which health care intervention works best for the diagnosis or treatment of a given disease or condition. While comparative effectiveness and personalized medicine evolved separately, these significant trends interface, increasingly, in the healthcare systems.

3 Sep 2010

BEST files initial public offering of common stock

Bruker Corporation,a leading global provider of high-performance scientific instruments, and Bruker Energy & Supercon Technologies, Inc. ("BEST"), a leading provider of superconducting technology and enabling tools and a Bruker subsidiary, today announced that BEST has filed a Form S-1 Registration Statement with the United States Securities and Exchange Commission relating to the proposed initial public offering (the "offering") of common stock of BEST.

3 Sep 2010

ForteBio launches Protein G biosensor for rapid detection of mammalian IgGs

ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its Dip and Read™ Protein G biosensor for rapid detection and quantification of numerous types of mammalian immunoglobulin (IgG), an antibody molecule, from solution. Because it runs on the company's label-free Octet instrumentation platform, the new biosensor enables such measurements with unprecedented speed, ease of use and cost-efficiency.

3 Sep 2010

Macro, Cornerstone team up to serve healthcare institutions

Macro Consultants LLC and Cornerstone Program Advisors LLC announce the combination of their service offerings in a partnership geared toward better serving healthcare institutions. This partnership will allow healthcare organizations which are undertaking capital projects and other improvements to benefit from a suite of project management services never before combined into a single offering.

3 Sep 2010

TCC gears up early intervention programs for families, children with autistic spectrum disorders

In preparation for the new school year The Children's Center's is gearing up their early intervention programs for families and children with autistic spectrum disorders between the ages 18 months to 6 years old. The Children's Center recognizes one of the fastest growing developmental disability in the United States affecting our children is Autism. That's why TCC is offering back to school support to families of children with autism spectrum disorder.

3 Sep 2010

Forbion Capital Partners announces final closing of FCF I, FCF II fund

Forbion Capital Partners, a leading investment firm dedicated to the life science sector, today announces the final closings of both FCF I Co-Invest Fund and of FCF II, raising a total of more than €190m ($240m). Forbion's €54m Co-Invest Fund aims to invest alongside FCF I in a select number of late-stage FCF I portfolio companies.

3 Sep 2010

Biopharmaceutical firms take steps to create greener working environments

Biopharmaceutical firms and other life science organizations are taking definitive steps toward creating greener working environments and developing more sustainable operations, reports Genetic Engineering & Biotechnology News (GEN).

3 Sep 2010

Accentus Medical signs licence agreement for Agluna anti-infective technology with Zimmer

Accentus Medical, a leading UK medical technology company that supplies advanced coatings and surface treatments to the medical device industry, announced today that it has signed a Licence and Services Agreement with Zimmer Holdings, Inc., a global market leader in musculoskeletal care. This agreement will enable the use of Accentus Medical's Agluna® anti-infective technology on a potentially broad range of Zimmer products.

3 Sep 2010

Scientists identify thousands of proteins that play a key role in compacting DNA

Scientists have built a clearer picture of how lengthy strands of DNA are concertinaed when our cells grow and divide, in a discovery could help explain how cell renewal can go wrong.

3 Sep 2010

NEJM publishes study on Xpert MTB/RIF test for rapid molecular detection of TB and rifampin resistance

Cepheid today announced that its Xpert® MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance." The complete study is now available online (http://www.nejm.org) and will appear in the September 9 print edition.

3 Sep 2010

Reducing emergency service delay by 10 minutes could result in death rate decline

Spanish researchers have calculated the probability of dying in road accidents on the basis of the time taken for the emergency services to arrive. Their conclusions are clear - reducing the time between an accident taking place and the arrival of the emergency services from 25 to 15 minutes would cut the risk of death by one-third.

3 Sep 2010

IPS examines agricultural funding in Africa

Inter Press Service examines how some African countries are benefiting from the global agriculture fund the G8 pledged $22 billion to in July 2009. According to the article, the Comprehensive Africa Agriculture Development Programme (CAADP), which seeks to increase African spending on agriculture to foster more growth, "has received a major boost as several countries have begun drawing" on the G8 money.

3 Sep 2010

Seattle Genetics achieves milestone on Agensys' initiation of AGS-16M8F ADC phase I trial for cancer

Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc. The milestone was triggered by Agensys' initiation of a phase I trial for AGS-16M8F, an ADC for the treatment of cancer utilizing Seattle Genetics' technology.

3 Sep 2010

New test detects TB faster, with more accuracy than current diagnostics, study says

A new molecular test for tuberculosis can diagnose the disease and detect a drug-resistant form of it in less than two hours and more accurately than current tests, according to the findings of a study published online in the New England Journal of Medicine on Wednesday, Reuters reports (Kelland, 9/1).

3 Sep 2010

AMIA launches non-profit Global Health Informatics Partnership

AMIA, the U.S.-based association for informatics professionals, has launched a non-profit, wholly owned subsidiary organization called the Global Health Informatics Partnership (GHIP) to serve as an international center for collaborative initiatives on health informatics. With generous operational support from AMIA, GHIP, aims to build grassroots networks of health informatics advocates and professionals that will result in strengthened health informatics capacity in low-resource settings, primarily in South America, Africa, and Asia.

3 Sep 2010

Alcon to launch AcrySof IQ ReSTOR Multifocal Toric intraocular lens outside US during 2010 ESCRS meeting

Alcon, Inc., the world's leader in eye care and cataract surgery, announced its launch of the AcrySof® IQ ReSTOR® Multifocal Toric intraocular lens (IOL) outside the United States during the 2010 European Society of Cataract and Refractive Surgeons (ESCRS) annual meeting in Paris, France. This new lens is built on Alcon's industry leading AcrySof® platform and is designed to provide cataract patients that have astigmatism a surgical option that delivers quality vision at all distances with increased spectacle independence.

3 Sep 2010

Researchers discover new class of edible nanostructures for energy storage

Sugar, salt, alcohol and a little serendipity led a Northwestern University research team to discover a new class of nanostructures that could be used for gas storage and food and medical technologies. And the compounds are edible.

3 Sep 2010

Celsion receives SBIR grant to develop heat sensitive liposomal technology for cancer treatment

Celsion Corporation, a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer".

3 Sep 2010

Scientists develop direct method to detect gene doping

Scientists at the universities in Tübingen and Mainz have developed a test that can provide conclusive proof of gene doping. "For the first time, a direct method is now available that uses conventional blood samples to detect doping via gene transfer and is still effective if the actual doping took place up to 56 days before," Professor Perikles Simon, MD, PhD from Johannes Gutenberg University Mainz, Germany explained on Thursday.

3 Sep 2010

Technology News and Research

Emerald BioStructures, SomaLogic announce strategic collaboration for SOMAmers

ECRI Institute's 17th Annual Conference to be held October 19-20, at NIH

BEST files initial public offering of common stock

ForteBio launches Protein G biosensor for rapid detection of mammalian IgGs

Macro, Cornerstone team up to serve healthcare institutions

TCC gears up early intervention programs for families, children with autistic spectrum disorders

Forbion Capital Partners announces final closing of FCF I, FCF II fund

Biopharmaceutical firms take steps to create greener working environments

Accentus Medical signs licence agreement for Agluna anti-infective technology with Zimmer

Scientists identify thousands of proteins that play a key role in compacting DNA

NEJM publishes study on Xpert MTB/RIF test for rapid molecular detection of TB and rifampin resistance

Reducing emergency service delay by 10 minutes could result in death rate decline

IPS examines agricultural funding in Africa

Seattle Genetics achieves milestone on Agensys' initiation of AGS-16M8F ADC phase I trial for cancer

New test detects TB faster, with more accuracy than current diagnostics, study says

AMIA launches non-profit Global Health Informatics Partnership

Alcon to launch AcrySof IQ ReSTOR Multifocal Toric intraocular lens outside US during 2010 ESCRS meeting

Researchers discover new class of edible nanostructures for energy storage

Celsion receives SBIR grant to develop heat sensitive liposomal technology for cancer treatment

Scientists develop direct method to detect gene doping

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News